| Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study B Cariou, S Hadjadj, M Wargny, M Pichelin, A Al-Salameh, I Allix, ... Diabetologia 63 (8), 1500-1515, 2020 | 934 | 2020 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 884 | 2021 |
| Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring D Deiss, J Bolinder, JP Riveline, T Battelino, E Bosi, N Tubiana-Rufi, ... Diabetes care 29 (12), 2730-2732, 2006 | 715 | 2006 |
| Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized … T Haak, H Hanaire, R Ajjan, N Hermanns, JP Riveline, G Rayman Diabetes Therapy 8, 55-73, 2017 | 613 | 2017 |
| Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance F Mauvais-Jarvis, E Sobngwi, R Porcher, JP Riveline, JP Kevorkian, ... Diabetes 53 (3), 645-653, 2004 | 395 | 2004 |
| Endocrinology of pregnancy: gestational diabetes mellitus: definition, aetiological and clinical aspects B Baz, JP Riveline, JF Gautier European journal of endocrinology 174 (2), R43-R51, 2016 | 341 | 2016 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 276 | 2021 |
| The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3 C Bellanné-Chantelot, C Carette, JP Riveline, R Valéro, JF Gautier, ... Diabetes 57 (2), 503-508, 2008 | 253 | 2008 |
| Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes T Haak, H Hanaire, R Ajjan, N Hermanns, JP Riveline, G Rayman Diabetes Therapy 8, 573-586, 2017 | 210 | 2017 |
| Management of drugs affecting blood glucose in diabetic patients with renal failure. G Charpentier, JP Riveline, M Varroud-Vial Diabetes & metabolism 26, 73-85, 2000 | 204 | 2000 |
| Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a … S Lablanche, MC Vantyghem, L Kessler, A Wojtusciszyn, S Borot, ... The lancet Diabetes & endocrinology 6 (7), 527-537, 2018 | 162 | 2018 |
| PAX4 gene variations predispose to ketosis-prone diabetes F Mauvais-Jarvis, SB Smith, CL May, SM Leal, JF Gautier, M Molokhia, ... Human molecular genetics 13 (24), 3151-3159, 2004 | 160 | 2004 |
| Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system JP Riveline, J Teynie, S Belmouaz, S Franc, D Dardari, M Bauwens, ... Nephrology Dialysis Transplantation 24 (9), 2866-2871, 2009 | 152 | 2009 |
| Clinical Characteristics and Diagnostic Criteria of Maturity-Onset Diabetes Of The Young (MODY) due to Molecular Anomalies of the HNF1A Gene C Bellanné-Chantelot, DJ Lévy, C Carette, C Saint-Martin, JP Riveline, ... The Journal of Clinical Endocrinology & Metabolism 96 (8), E1346-E1351, 2011 | 113 | 2011 |
| High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes E Sobngwi, JF Gautier, JP Kevorkian, JM Villette, JP Riveline, S Zhang, ... The Journal of Clinical Endocrinology & Metabolism 90 (8), 4446-4451, 2005 | 103 | 2005 |
| Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications JP Riveline, N Danchin, F Ledru, M Varroud-Vial, G Charpentier Diabetes & metabolism 29 (3), 207-222, 2003 | 103 | 2003 |
| Metabolic roles of PGC-1α and its implications for type 2 diabetes A Besseiche, JP Riveline, JF Gautier, B Bréant, B Blondeau Diabetes & metabolism 41 (5), 347-357, 2015 | 100 | 2015 |
| Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year … JP Riveline, P Schaepelynck, L Chaillous, E Renard, A Sola-Gazagnes, ... Diabetes Care 35 (5), 965-971, 2012 | 99 | 2012 |
| The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes M Laloi-Michelin, T Meas, C Ambonville, C Bellanné-Chantelot, S Beaufils, ... The Journal of Clinical Endocrinology & Metabolism 94 (8), 3025-3030, 2009 | 98 | 2009 |
| Polymorphisms in Type II SH2 domain–containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome PJ Kaisaki, M Delépine, PY Woon, L Sebag-Montefiore, SP Wilder, ... Diabetes 53 (7), 1900-1904, 2004 | 97 | 2004 |
